Subsidiaries
HTDS is a holdco of a China based Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Mellow Hope is the biggest exporter of Biological Vaccines in China. Based on the cooperation with Institutes of Medical Biology and Pharmaceutical manufacturers, Mellow Hope provides a wide range of vaccines with high quality, safety and efficacy.
Other controling interests include an East European (Serbian) medical company, Slavica Biochem whose experts are performing cutting edge research in the field of neurological impairments in Multiple Sclerosis (MS) and Traumatic Brain Injury (TBI). The primary focus of Slavica Biochem is to investigate novel therapeutic approaches in treatment of these disorders of the CNS (central nervous system), as well as to enhance and modify existing approved drugs such as VIRAZOLE®.
Collagenna - Created using pure, natural and odourless 100% Soluble Native Marine Collagen, Collagenna Skin Care products are the result of extensive research and development by Canadian scientists. Designed to nourish, repair and rejuvenate the essential ingredients of the skin, Collagennas unique skin care method replenishes proteins, lipids and sugars.
HTDS Bio Life - Revolution in treatment for pre-term labor and induction of labor that affect millions of women and newborn each year!
MELEM SECRET is part of a new generation of cosmetics that use only natural source, active ingredients. No parabens and no animal testing. It is the ultimate in skin care for people who care about what they put onto their skin and into their bodies.
Company News
-
Hard to Treat Diseases, Inc. (HTDS) Reports from Mina Mar's 2nd Annual Shareholders Conference
-
Positive influence of hyperbaric oxygenation on recovery from brain trauma
-
Hard to Treat Diseases (HTDS) Plans a Share Buyback Program - March 29, 2010
-
RD expenditures 2009
-
Hard to Treat Diseases (HTDS) Resolves Its Short Position with Scottrade - Shenzen, China, March 11, 2010 - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) announces that Scottrade lifted trading restriction on the HTDS security. Scottrade, the American discount retail brokerage firm, removed the restriction of online trading and buys of HTDS security, as HTDS successfully resolved the issue regarding the company's short position. The company sees this a right move from the brokerage firm and will work diligently to achieve and lift all similar restrictions with brokerages that filed HTDS in their bad books.
-
Hard to Treat Diseases (HTDS) Melem Secrets' Completes Merger - BEIJING, CHINA, Feb. 25 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) - Further to the previously announced cosmetics merger (press release Feb 5, 2010) negotiations with the cosmetic company Melem Secrets, and other business matters the company is pleased to report that it has completed a cosmetic micro-conglomerate merger.
-
Chile Buys 2 Million Doses of Swine-Flu Vaccine SANTIAGO The Chilean government has purchased 2 million doses of the vaccine against the AH1N1 flu virus for the immunization campaign that begins in the second half of March, the Health Ministry said.
Read Full Report Here